ABSTRACT
Oxaliplatin is a routinely used drug in the treatment of colorectal cancer. However, development of resistance is a major hurdle of the chemotherapy success. Defects in cellular accumulation represent a frequently reported feature of cells with acquired resistance to platinum drugs. Nevertheless, the mechanisms of oxaliplatin uptake and their role in oxaliplatin resistance remain poorly elucidated. The aim of this study was to investigate the relevance of copper transporter 1 (CTR1) and organic cation transporters 1-3 (OCT1-3) for oxaliplatin uptake and resistance to the drug in sensitive and oxaliplatin-resistant ileocecal colorectal adenocarcinoma cells. Co-incubation with copper(ii) sulfate, a CTR1 substrate, significantly decreased oxaliplatin accumulation but not cytotoxicity in both cell lines. Pre- as well as co-incubation with the OCT1 inhibitor atropine led to a significant reduction in oxaliplatin accumulation in sensitive but not in resistant cells. However, oxaliplatin cytotoxicity was also decreased in the presence of atropine in both cell lines. Cimetidine, an inhibitor of OCT2, induced a significant reduction in the cellular accumulation and potency of oxaliplatin in sensitive and resistant cells. An inhibitor of OCT3, decynium-22, had no influence on oxaliplatin accumulation and cytotoxicity in either cell line. No differences in the transporter expressions were observed between the cell lines, drug-treated or not, either at the mRNA or protein levels. A fluorescent oxaliplatin derivative CFDA-oxPt co-localized with CTR1, OCT1 and OCT2 in sensitive cells, but only with CTR1 and OCT2 in the resistant cell line. Our results suggest that oxaliplatin is transported into the cell by CTR1 in both cell lines. However, contribution of CTR1-mediated uptake to resistance seems unlikely. Uptake of oxaliplatin via OCT1 appears to take place in the sensitive but not in the resistant cell line underscoring the transporter relevance for oxaliplatin resistance. OCT2 is likely to be involved in the uptake of oxaliplatin to a similar extent in both cell lines suggesting no major contribution of this transporter to resistance. In contrast, OCT3 appears to be irrelevant for oxaliplatin transport into the cell and resistance.
Subject(s)
Cation Transport Proteins/metabolism , Colorectal Neoplasms/metabolism , Drug Resistance, Neoplasm , Octamer Transcription Factor-1/metabolism , Octamer Transcription Factor-3/metabolism , Organic Cation Transporter 2/metabolism , Oxaliplatin/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis , Biological Transport , Cation Transport Proteins/genetics , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/pathology , Copper Transporter 1 , Gene Expression Regulation, Neoplastic , Humans , Octamer Transcription Factor-1/genetics , Octamer Transcription Factor-3/genetics , Organic Cation Transporter 2/genetics , Tumor Cells, CulturedABSTRACT
A mini library of HDAC inhibitors with peptoid-based cap groups was synthesized using an efficient multicomponent approach. Four compounds were identified as potent HDAC6 inhibitors with a selectivity over other HDAC isoforms. The most potent HDAC6 inhibitor revealed remarkable chemosensitizing properties and completely reverted the cisplatin resistance in Cal27 CisR cells.
Subject(s)
Histone Deacetylase Inhibitors/chemical synthesis , Peptoids/chemistry , Drug Design , Histone Deacetylase Inhibitors/chemistry , Histone Deacetylase Inhibitors/pharmacology , Molecular Docking SimulationABSTRACT
Activation of the G protein-coupled free fatty acid receptor 1 (FFA1; formerly known as GPR40) leads to an enhancement of glucose-stimulated insulin secretion from pancreatic ß-cells. TUG-469 has previously been reported as a potent FFA1 agonist. This study was performed to confirm the higher in vitro potency of TUG-469 compared to the reference FFA1 agonist GW9508 and to prove in vivo activity in a pre-diabetic mouse model. The in vitro pharmacology of TUG-469 was studied using Ca(2+)-, cAMP-, and impedance-based assays at recombinant FFA1 and free fatty acid receptor 4, formerly known as GPR120 (FFA4) expressing 1321N1 cells and the rat insulinoma cell line INS-1. Furthermore, we investigated the systemic effect of TUG-469 on glucose tolerance in pre-diabetic New Zealand obese (NZO) mice performing a glucose tolerance test after intraperitoneal administration of 5 mg/kg TUG-469. In comparison to GW9508, TUG-469 showed a 1.7- to 3.0-times higher potency in vitro at 1321N1 cells recombinantly expressing FFA1. Both compounds increased insulin secretion from rat insulinoma INS-1 cells. TUG-469 is > 200-fold selective for FFA1 over FFA4. Finally, a single dose of 5 mg/kg TUG-469 significantly improved glucose tolerance in pre-diabetic NZO mice. TUG-469 turned out as a promising candidate for further drug development of FFA1 agonists for treatment of type 2 diabetes mellitus.
Subject(s)
Aniline Compounds/pharmacology , Hypoglycemic Agents/pharmacology , Insulin-Secreting Cells/drug effects , Phenylpropionates/pharmacology , Prediabetic State/drug therapy , Receptors, G-Protein-Coupled/agonists , Animals , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Calcium Signaling/drug effects , Cell Line, Tumor , Cyclic AMP/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Insulin/blood , Insulin-Secreting Cells/metabolism , Male , Methylamines/pharmacology , Mice , Mice, Obese , Prediabetic State/blood , Prediabetic State/diagnosis , Propionates/pharmacology , Rats , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Recombinant Proteins/metabolism , Time Factors , TransfectionABSTRACT
Scanning electron microscopic (SEM) studies on intrafusal muscle fibers and their various sensory and motor endings are not available thus far although SEM greatly increases the resolution power for analyzing surface structures in comparison to light microscopic preparations. From a total of 68 isolated muscle spindles in lumbrical muscles of Wistar rats, only one primary sensory ending could be isolated. Secondary sensory endings were of an annulospiral, a flat, cuff-shaped, or a more complicated branched type; they were always completely surrounding intrafusal muscle fibers. Motor terminals were more focally arranged not surrounding the muscle fibers. Three types could be distinguished. Collagen fibrils were seen to insert on capsular elements as well as on the surface of intrafusal muscle fibers. Thus SEM helps understanding the most complicated electromechanical system for motor control.